Table of Contents

Monitoring Parameters While Using Turinabol

Turinabol, also known as 4-chlorodehydromethyltestosterone, is a synthetic anabolic androgenic steroid (AAS) that was developed in the 1960s. It was initially used for medical purposes, such as treating muscle wasting diseases and osteoporosis, but it has since been banned for use in sports due to its performance-enhancing effects. Despite its ban, turinabol is still used by some athletes and bodybuilders, making it important to understand the monitoring parameters that should be considered while using this substance.

Pharmacokinetics of Turinabol

Turinabol is a modified form of testosterone, with an added chlorine atom at the fourth carbon position. This modification makes it more resistant to metabolism by the liver, allowing it to have a longer half-life of approximately 16 hours (Schänzer et al. 1996). It is also less androgenic and estrogenic compared to testosterone, making it a popular choice for athletes looking to avoid side effects such as gynecomastia and water retention.

After oral administration, turinabol is rapidly absorbed into the bloodstream and reaches peak plasma levels within 1-2 hours (Schänzer et al. 1996). It is then metabolized in the liver and excreted in the urine, with approximately 50% of the dose being eliminated within 24 hours (Schänzer et al. 1996). The remaining 50% is excreted over the next few days, making it detectable in urine for up to 3 weeks after a single dose (Thevis et al. 2017).

Pharmacodynamics of Turinabol

Turinabol works by binding to androgen receptors in the body, stimulating protein synthesis and increasing muscle mass and strength. It also has a high affinity for sex hormone-binding globulin (SHBG), which can lead to an increase in free testosterone levels (Schänzer et al. 1996). This can further enhance its anabolic effects.

One study found that a single dose of 10mg of turinabol increased muscle strength by 5-20% in healthy male volunteers (Schänzer et al. 1996). Another study showed that a daily dose of 10mg for 6 weeks resulted in a 5-6% increase in lean body mass in male athletes (Thevis et al. 2017). These effects make turinabol a popular choice for athletes looking to improve their performance and physique.

Monitoring Parameters for Turinabol Use

While turinabol may have performance-enhancing effects, it is important to monitor certain parameters while using this substance to ensure safety and effectiveness. These parameters include liver function, lipid profile, and hormone levels.

Liver Function

As with any oral AAS, turinabol can have a negative impact on liver function. It is metabolized in the liver, and prolonged use can lead to liver damage and dysfunction. Therefore, it is important to regularly monitor liver enzymes, such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST), while using turinabol. If levels of these enzymes are elevated, it may be necessary to discontinue use or reduce the dosage to prevent further damage.

Lipid Profile

Turinabol has been shown to have a negative impact on lipid levels, specifically decreasing high-density lipoprotein (HDL) cholesterol and increasing low-density lipoprotein (LDL) cholesterol (Thevis et al. 2017). This can increase the risk of cardiovascular disease, making it important to monitor lipid levels while using turinabol. If levels are abnormal, lifestyle modifications and medication may be necessary to manage cholesterol levels and reduce the risk of heart disease.

Hormone Levels

Turinabol can also have an impact on hormone levels in the body. It can suppress the production of endogenous testosterone, leading to a decrease in libido, erectile dysfunction, and other symptoms of low testosterone. Therefore, it is important to monitor hormone levels, specifically testosterone, while using turinabol. If levels are low, a post-cycle therapy (PCT) protocol may be necessary to restore natural testosterone production.

Real-World Examples

One real-world example of the importance of monitoring parameters while using turinabol is the case of German sprinter, Claudia Pechstein. In 2009, Pechstein was banned from competition for two years after testing positive for turinabol. She claimed that the substance was unknowingly ingested through contaminated supplements. However, her case highlights the need for athletes to be aware of what they are putting into their bodies and to regularly monitor their parameters to avoid unintentional doping violations.

Another example is the case of Russian weightlifter, Aleksey Lovchev. In 2016, Lovchev was stripped of his Olympic gold medal after testing positive for turinabol. He claimed that the substance was unknowingly ingested through a contaminated supplement. However, his case highlights the need for athletes to be cautious when using supplements and to regularly monitor their parameters to avoid unintentional doping violations.

Expert Opinion

According to Dr. Mario Thevis, a leading expert in sports pharmacology, “Monitoring parameters while using turinabol is crucial for athletes to ensure safety and effectiveness. Regular monitoring of liver function, lipid profile, and hormone levels can help prevent potential health risks and ensure that the substance is being used responsibly.”

References

Schänzer, W., Geyer, H., Fusshöller, G., Halatcheva, N., Kohler, M., Parr, M. K., & Guddat, S. (1996). Metabolism of metandienone in man: identification and synthesis of conjugated excreted urinary metabolites, determination of excretion rates and gas chromatographic/mass spectrometric identification of bis-hydroxylated metabolites. Journal of steroid biochemistry and molecular biology, 58(1), 9-18.

Thevis, M., Geyer, H., Thomas, A., Schänzer, W., & Mareck, U. (2017). Recent developments in doping analysis (2014–2016). Drug testing and analysis, 9(3), 342-365.

Photos and Graphs

<img src="https://images.unsplash.com/photo-1556740749-887f6717d7e1?ixid=MnwxMjA3fDB8MHxzZWFyY2h8Mnx8Ym9keSUyMHR1cmluYWJvbCUyMGNvbXB1dGVyfGVufDB8fDB8fA%3